Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Infant Study of Inhaled Saline in Cystic Fibrosis (ISIS)

This study has been completed.
Sponsor:
Collaborators:
Cystic Fibrosis Foundation Therapeutics
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
CF Therapeutics Development Network Coordinating Center
ClinicalTrials.gov Identifier:
NCT00709280
First received: July 1, 2008
Last updated: February 11, 2013
Last verified: February 2013